Elliot Libling, MD
Otolaryngology · Glendale, AZNPI 1528096989
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,827 of the $2,100 with a category attached, or 87.0%. 16 manufacturers reported payments, led by Stryker at 34.1% of the total.
Across 72 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$716
- Optinose US, Inc.$270
- Sanofi$211
- Aerin Medical Inc.$203
- GSK$201
- Inspire Medical Systems, Inc.$155
- plus $343 from 10 others
What the payments were for
- Travel & lodging$27313%
- Food & beverage$1,82787%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 8 | $716 |
| Optinose US, Inc. | 18 | $270 |
| Sanofi | 10 | $211 |
| Aerin Medical Inc. | 4 | $203 |
| GSK | 14 | $201 |
| Inspire Medical Systems, Inc. | 2 | $155 |
| Medtronic(2 entities) | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| Novartis | 2 | $37 |
| Ambu Inc. | 1 | $30 |
| Kaleo, Inc. | 1 | $25 |
| Intersect ENT, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Phadia US Inc. | 1 | $15 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,100 in reported general payments places this provider in the 60th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 69 | $2,054 |
| Fluticasone Propionate | 59 | $1,309 |
| Ofloxacin | 39 | $1,194 |
| Azelastine Hcl | 22 | $585 |
| Mupirocin | 31 | $260 |
| Ciprofloxacin Hcl | 16 | $205 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $160 |
| Prednisone | 32 | $77 |
| Montelukast Sodium | 12 | $73 |
| Azithromycin | 20 | $59 |
| Cephalexin | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Glendale
- Brandon FornwaltGlendale$13K
- Ravi AgarwalGlendale$3K
- Daniel CharousGoodyear$196K
- Jordan WeinerScottsdale$129K
- Lisa GrunebaumScottsdale$121K
- Peter KaiserPhoenix$114K
- Glenn RothmanMesa$51K
- Farhan TaghizadehPhoenix$46K
- Eugene ChangTucson$44K
- Shawn StevensPhoenix$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.